title: Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy.
abstract: We present a patient with autoimmune autonomic ganglionopathy (AAG) who had persistently positive ganglionic nicotinic acetylcholine receptor antibody levels despite immunosuppressive therapy. Rituximab-based therapy for an incidental lymphoma was associated with prolonged symptomatic and serological control of AAG.
authors.affiliation: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. guptaarjun90@gmail.com.
authors.forename: Arjun
authors.identifier: http://orcid.org/0000-0003-0875-4731
authors.initials: A
authors.lastname: Gupta
authors.affiliation: Department of Gastroenterology and Hepatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
authors.forename: Samar
authors.initials: S
authors.lastname: Harris
authors.affiliation: Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
authors.forename: Steven
authors.initials: S
authors.lastname: Vernino
authors.affiliation: Department of Hematology, University of Texas Southwestern Medical Center, Seay Biomedical Building, 2201 Inwood Road, Dallas, TX, 75390-8562, USA. Harris.Naina@UTSouthwestern.edu.
authors.forename: Harris V
authors.initials: HV
authors.lastname: Naina
mesh_terms: D020274:Autoimmune Diseases of the Nervous System / Q000175:diagnosis* / Q000188:drug therapy*; D005725:Ganglia, Autonomic / Q000473:pathology*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab / Q000627:therapeutic use*
chemical_list: D007155:Immunologic Factors; D000069283:Rituximab
keywords: Autoimmune autonomic ganglionopathy; Management; Rituximab